ARCHIVES

Three researchers share Paul Marks Prize.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

NIH To Give 3 Percent Increase to Grants

March 20, 2009

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Perifosine Increases PFS In Phase II Study

December 30, 2011

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Funding Opportunities.

April 11, 2003

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981